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Abstract. During extracorporeal circulation (ECC), blood is periodically sampled and analyzed to maintain the
blood-gas status of the patient within acceptable limits. This protocol has well-known drawbacks that may be over-
come by continuous monitoring. We present the characterization of a new pH sensor for continuous monitoring in
ECC. This monitoring device includes a disposable fluorescence-sensing element directly in contact with the blood,
whose fluorescence intensity is strictly related to the pH of the blood. In vitro experiments show no significant
difference between the blood gas analyzer values and the sensor readings; after proper calibration, it gives a cor-
relation of R > 0.9887, andmeasuring errors were lower than the 3% of the pH range of interest (RoI) with respect to
a commercial blood gas analyzer. This performance has been confirmed also by simulating a moderate ipothermia
condition, i.e., blood temperature 32°C, frequently used in cardiac surgery. In ex vivo experiments, performed with
animal models, the sensor is continuously operated in an extracorporeal undiluted blood stream for a maximum of
11 h. It gives a correlation of R > 0.9431, and a measuring error lower than the 3% of the pH RoI with respect to
laboratory techniques. © 2013 Society of Photo-Optical Instrumentation Engineers (SPIE) [DOI: 10.1117/1.JBO.18.2.027002]
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1 Introduction
Extracorporeal circulation (ECC) is mainly applied in cardiopul-
monary bypass, extracorporeal membrane oxygenation, and
hemodialysis. Usually, during ECC, blood samples are drawn
intermittently and analyzed by a blood gas analyzer. Major prob-
lems associated with this intermittent sampling are: (1) high cost
of the blood gas analyzer and required reagents thus analyses are
often performed only after adverse events; (2) there is a risk of
blood loss and infection; and (3) therapeutic response can only
be made after a delay. Considerable spontaneous variability in
blood gases and other quickly changing analytes that occur dur-
ing ECC require clinical decisions made on the basis of trends
observed with continuous monitoring. Usually, the information
of interest includes hemoglobin saturation, hematocrit, blood
gases (O2, CO2), pH, electrolytes (Naþ, Kþ, Ca2þ, Cl2), certain
metabolites (glucose, lactate, urea, creatinine), and physical
measurands (temperature, pressure, flow). Several sensors
capable of continuously monitoring these parameters have been
so far proposed.1,2 Nevertheless, despite tremendous technologi-
cal efforts, the proposed technologies are not yet sufficiently
reliable and economic to be used routinely in ECC and frequent
intermittent measurements made by a blood gas analyzer near
the bedside are still the standard practice. Since ECC through
flow cuvettes offers a perfect optical access to circulating
blood, several optical approaches have been considered,3–9
and few commercial optical continuous intravascular blood
gas monitoring devices are nowadays available: Paratrend 7þ
(PT7þ) for adults and Neotrend (NT) for newborns, both based
on optical absorption and reflectance methods.10 However, they
have been rarely used due to their instability and inaccura-
cies.11,12 In ECC, haematic pH is one of the most interesting
blood parameter. pH, in fact, is strongly related to the function-
ing of important organs such as lung, heart, liver, and kidney.
The haematic pH, in healthy human beings, is always between
7.30 and 7.45, thanks to the bicarbonate buffering system.
Nevertheless, a little variation of pH can produce great damages
for the body. Many efforts have been spent on the development
of pH sensors to be applied in ECC. Continuous blood pH mea-
surements can be made potentiometrically via ion-selective elec-
trodes or transistors. These devices are based on ionophores that
may leach out of the ion-selective membranes, thus resulting in
lower stability and short lifetime.13 This stability issue limits the
use of ion-selective electrodes or transistors in ECC. Attempts to
use electrochemical sensors were hampered by protein deposi-
tion on the active or reference electrodes that prevents their use
unless regular recalibration.2 While promising, none of these
methods are suitable for continuous monitoring in ECC. As
for the other quantities of interest in ECC, there has been con-
siderable interest in optical methods of determining pH. In
literature, proposed pH sensors are mainly based on the
immobilization of pH-sensitive absorbing dyes14–16 or fluoro-
phores17,18 on a solid substrate. One of the major limitation of
such a sensor is still the dye leaching into blood,19 that, besides
problems related to signal stability, can represent a risk for the
patient, if the dye is toxic. A further disadvantage of the sensors
based on fluorophores is their propensity for photobleaching.19
For all these reasons, while many pH optical sensors have been
proposed for continuous pH monitoring, in vivo results have not
been reported so far. In the present study, we use a novel
pH sensor based on a polymeric sensing substrate, directly in
contact with the blood, encapsulating the pH-indicator.20 TheAddress all correspondence to: Luca Ferrari, University of Modena and Reggio
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pH-sensitive fluorophore is the fluorescein O-methacrylate
97%, which can be covalently linked to the polymeric sensing
element. This sensing approach offers several advantages: (1)
simple fabrication and low-cost, thus the sensing element is dis-
posable; (2) thanks to the covalent link, minimal leaching of the
fluorophore into the blood; (3) biocompatibility (fluorescein is
used in several medical practises, e.g., fluoroangiography); and
(4) mechanical robustness. The interrogation optical head was
realized using a low-cost light source [light-emitting diode
(LED)] and two photodiodes, to monitor both the power emitted
by the LED and the fluorescence signal emitted by the sensing
element. Fluorophores photobleaching was compensated by
proper modulation of the optical source.21 Whole blood was
used in this work to demonstrate the monitoring performances
both in vitro and ex vivo experiments over long periods. In the
next section a brief introduction of the principle of measurement
is given whereas the optical transducer, flow cuvette and the
electronic circuitary are described in the first paragraph of
Sec. 3. Sections 3.3, 3.4, and 3.5 deal with the description of
the experimental setup and the measurement procedure, while
the results of the sensor characterization, both in vitro and in
ex vivo are reported in Sec. 4. Finally, conclusions are drawn
and discussed in Sec. 5.
2 Theoretical Background
The proposed sensing approach consists in the fluorometric
determination of pH.22 Fluorescence measurements of pH are
based on the detection of the concentration of the acid and base
forms of the fluorophore and are not related to activity of the
hydrogen ions as in potentiometric pH determinations. How-
ever, the unknown ionic strength of the sample affects the
equilibrium constant, and hence the pH calculated from the mea-
sured degree of dissociation of the indicator. Thus this approach
requires a proper calibration procedure. It is already known that
fluorescence intensity of fluorescein molecule is dramatically
reduced at acidic pH when excitation is performed at 490 nm.23
In particular, as discussed in the next section, we deploy the pH-
dependency of the emission spectra of the fluorescein O-meth-
acrylate 97%. The response curve of this sensing approach
derives from the mass-action law relationship between pH
and radiation intensity.24 Considering the free dye, if the fluo-
rescence intensity of the fully protonated system is Imin and
assuming equal to Imax the fluorescence contribution of the
deprotonated system, the intensity of fluorescence emission Is
in the presence of the sample under test is then converted to pH,
by the relation:25
















where pKa is the acid-base constant of the indicator, Io is the
excitation light intensity, and Iratio is equal to Is∕Io. It has to be
noticed that the parameters Iratio ¼ Is∕Io, Imax∕Io, and Imin∕Io
are insensitive to possible small fluctuations of the excitation
light intensity. Considering the dye covalently linked to the
polymer matrix, Eq. (1) is modified25,26 and become:









where b is a numerical coefficient, introduced to determine the
slope of the function between Imax and Imin. In fact, the chemical
and physical properties of the matrix encapsulating the dye (e.g.,
polarity and viscosity) could affect its sensitivity near the pKa,
thus having different slopes for the same indicator in different




























The pH of blood is related to the constituents of the bicar-
bonate buffer system by the modified Henderson-Hasselbalch
equation:27





where pKaH2CO3 is the acid dissociation constant of the carbonic
acid, which is equal to 6.1, ½HCO−3  is the concentration of bicar-
bonate in the blood, and ½H2CO3 is the concentration of car-
bonic acid in the blood. Considering the partial pressure of
carbon dioxide, pCO2, rather than ½H2CO3, Eq. (4) can be
written as:





Equation (5) provides a pH value for healthy human beings
between 7.30 and 7.45. These pH values are very close to the
pKa of our sensing membrane, i.e., Iratio ¼ ðImax þ IminÞ∕2Io,
thus the argument of the logarithmic function in Eq. (2) is close
to one. According to the first-order Taylor polynomial of the
logarithmic function, the approximation of Eq. (2) is:









Since pH values are very close to the pKa of our sensing








is close to zero. According to the first-order Taylor polynomial
of the rational function, Eq. (6) can be rewritten as:
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Rewriting Eq. (8) in terms of Iratio, it gives:





2 · b · logðeÞ
þ Imax þ Imin
2Io
¼ A · pHþ B; (9)
where
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3 Materials and Methods
The measuring device and the experimental setups have been
developed to evaluate the approach under in vitro conditions
on fresh cow blood and ex vivo via monitoring of blood pH
in animal models, i.e., a pig and a sheep, undergoing surgery
with ECC.
3.1 Optical Transducer and Flow Cuvette
As schematically shown in Fig. 1, the optical transduction of the
pH value is based on the fluorescence of a polymeric film
directly in contact with the blood flowing in the ECC.
Through an optical head, the fluorescein is excited and the
emitted fluorescence signal is collected; finally, a driver, front-
end, and signal processing electronics drives the excitation light
source and acquires the information of interest.
The polymeric sensing matrix is one of the most important
element of the sensor, since it is directly in contact with the
blood. So it needs high mechanical strength, but, at the same
time, it has to guarantee a fast mass transfer, and in particular
penetration of hydrogen ions, in order to improve the response
time. Finally, it has to be characterized by a low dye leaching. A
hydrophilic polymer has been chosen as the matrix, and it has
been realized using hydroxyethyl methacrylate (HEMA) which
is biocompatible, and it is characterized by a good thermody-
namic affinity with water.28 Moreover, in order to improve
the mechanical strength and to avoid a too high swelling, como-
nomers with functionality four have been added. In particular, a
reactive divinyl terminated polyether macromer has been used to
increase the chain mobility within the polymer matrix, thus to
improve the response time. The fluoresceinO-methacrylate 97%
is used as the indicator. Since it contains an acrylate group, it is
able to covalently link to the polymeric matrix, thus avoiding
the dye leaching. The polymeric solution is deposited on poly-
vinyl chloride (PVC) round substrates and is photopolymerized
in an ultra violet (UV)-oven. A picture of the polymeric sensing
element, placed in a flow cuvette, is shown in Fig. 2.
The polymeric sensing element is interrogated by an optical
head, which has to excite the fluorescein, to collect the fluores-
cence signal and to monitor the power of the light source. Since
the fluorescein O-methacrylate is characterized by an excitation
spectrum centered at the wavelength of about λpeak ¼ 490 nm,
a blue LED (λpeak ¼ 480 nm) has been used to excite it.
Moreover, two photodiodes have been used as photodetectors,
one to collect the fluorescence signal and one to monitor the
optical power emitted by the LED, thus avoiding the influence
of fluctuations of the optical power of the LED. Finally, as usual
in fluorescence measurements, two optical filters have been
used; in particular, an excitation filter (low-pass filter, λcutoff ¼
495 nm) on the light path of the excitation beam and an emis-
sion filter (bandpass filter, Δλ ¼ 515 − 535 nm) on the light
path of the fluorescence signal. A schematic representation and















Fig. 1 Schematic representation of the measurement principle. A poly-
meric sensing matrix, placed in the flow cuvette directly in contact with
the blood, is interrogated by the optical head properly driven by the
electronic circuitry.



















Fig. 3 Schematic representation (a) and a picture (b) of the optical head.
It consists of a blue LED, two photodiodes (to monitor the power emitted
by the LED and to collect the fluorescence signal), and finally two opti-
cal filters: an excitation filter on the light path of the excitation beam and
an emission filter on the light path of the fluorescence emission beam.
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3.2 Driving Electronics and Analog Signal Processing
Circuitry
The operation of the measuring device is based on the electronic
circuitry for exciting the blue LED and conditioning the signals
provided at the photodiode detectors output. According to our
previous paper,21 the blue LED is excited by current pulses
(duration 800 ms) at a frequency of 0.125 Hz. During the pulse
the current was modulated sinusoidally at a frequency of
6.06 kHz. This double modulation allows us to reduce the
effects of photobleaching21 and improve the signal-to-noise ratio
operating a proper demodulation of the photodetectors output.
The front-end electronics consists in two channels devoted to
the processing of the monitor and fluorescence photogenerated
current signals. Each channel includes: (1) a low-noise trans-
impedance preamplifier; (2) a high-Q bandpass filter with center
frequency at 6.06 kHz; (3) a lock-in amplifier; (4) a lowpass
filter with a 70-Hz passband cutoff, and (5) an analog-to-digital
converter. Figure 4 shows the block diagram of the electronics
and two pictures of the measuring system including the
optical head.
3.3 Regression Model
Iratio has been estimated by the voltage ratio, Vratio, between the
signals generated by the front-end electronics, i.e., Vfluo and
Vmon. Since the proportionality coefficient between Vratio and
Iratio and parameters A and B in Eq. (9) are unknown, the rela-
tionship between pH and Vratio was determined using a linear
regression model. Starting from Eq. (9), we introduced two
regression coefficients Ã and B̃ calculated through a least
squares method relating the values of Vratio and the actual pH
values measured by the blood gas analyzer according to the
regression model:
Vratio ¼ Ã · pHþ B̃: (11)
This linear approximation is considered to be valid in the pH
range of interest (RoI) (6.9 to 8).
3.4 Experimental Protocol for In Vitro Test
Figure 5 shows the mock system assembled to simulate the
blood condition during ECC. It consists of: (1) a centrifugal
pump, capable of guaranteeing a flux up to 6 L∕min; (2) a
heat exchanger based on the Peltier effect (temperature ranging
15°C to 39°C); (3) an oxygenator; and (4) an arterial/venous
bubble filter. The whole circuit volume, including the centrifu-
gal pump, the heat exchanger, the oxygenator, the arterial-
venous bubble filter and the tubing set is 760 ml. The flow
cuvette was positioned in the tubing connecting the filter and
the reservoir, on the arterial line. The optical probe was fixed
to the flow cuvette according to the setup shown in Fig. 3,






































Fig. 4 Block diagram of the electronics (a) and pictures of the measuring system including the optical head, back view (b) and front view (c).
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analyzed by the front-end electronics that generates Vratio. A
constant blood flow (2 L∕min) was maintained throughout
the experiments. Blood samples were obtained from the extra-
corporeal line close to the flow cuvette (sampling valve). The
protocol described above was repeated for two different blood
temperatures, 37°C and 32°C, since frequently in cardiac sur-
gery a moderate ipothermia condition is induced. The depend-
ence of the sensor on the blood saturation was not investigate,
since it is correlated with the variation of pH.
The cow was exsanguinated at local slaughterhouse 1 h
before the experiment. The collected blood was stored in hepa-
rinized container at 4°C during the transportation. Whole blood
is an intrinsically complex fluid and difficult to manipulate,
thus great care was devoted to not alterate natural condition
of the sample. Before the experiment, the blood was diluted
with saline solution and used to fill the reservoir with 3 L of
fluid. The hemodilution was adjusted to provide sample with
a hematocrit of 33% to 34%. The values of partial pressure
of oxygen (pO2), carbon dioxide (pCO2), and pH were adjusted
to normal physiological range previous the measurement ses-
sion. All blood gas analyses were performed with a commercial
blood gas analyzer (ABL, Radiometer A/S, Copenhagen,
Denmark).
3.5 Experimental Protocol for Ex Vivo Test
The study was approved by the the Animal Care Ethical
Committee of the University of Modena and Reggio Emilia.
The experiments followed the recommendations described in
the Italian law (D.L. 27-1-1992 n. 116). A veterinary doctor
was constantly involved in the activities to control animals well-
ness and health. First experiment was performed on an adult
female pig (see note, Table 1). To confirm the results obtained
during this experiment a second sensor has been tested on an
adult female sheep (see note, Table 2).
During each surgery the sensor (different sensing elements
have been used in the two experiments) was attached to the
arterial line of the ECC circuit. A total of 20 samples were
analyzed by a a blood gas analyzer (ABL, Radiometer A/S,
Copenhagen, Denmark) during the two surgeries with pH vary-
ing in the range 7.2 and 7.5. The experimental setup for ex vivo
evaluation of the measuring system is shown in Fig. 6. It consists
of the standard ECC setup including the flow cuvette placed
between the animal and the arterial filter.
The following blood parameters were monitored during the
experiment: blood flow rate by flow probes (H9XL Flow Probe,
Transonic Systems Inc., Artisan Sci. Co., Champaign, Illinois),
blood pressures by digital sensors (DPI 705, Druck Ltd,
Leicester, England), blood temperatures by thermistor probes
(Exacon® Medical Temperature Probe, Exacon Scientific A/
S, Roskilde, Denmark) and digital thermometer (Omega
HH41, Engineering Inc., Stamford, Connecticut), blood gases
(paO2: oxygen partial pressure in the arterial blood; pvO2: oxy-
gen partial pressure in the venous blood; paCO2: carbon dioxide
partial pressure in the arterial blood; SaO2: hemoglobin oxygen
saturation in the arterial blood) by a blood gas analyzer (ABL,
Radiometer A/S, Copenhagen, Denmark); hematocrit by a HCT
minicentrifuge (Hematocrit Centrifugette 4203, ALC Inter-
national S.r.L., Cologno Monzese, Milan, Italy), blood electro-
lytes and activated clotting time (ACT) (ACT Plus™, Medtronic















Fig. 5 Block diagram (a) and picture (b) of the mock system realized to
simulate the blood condition during ECC. It consists of a centrifugal
pump, an oxygenator, a heat exchanger, an arterial/venous bubble
filter, a sampling valve, a flow cuvette, and tubings.
Table 1 Details of the pig involved in the ex vivo experiment.
Race: Large white (Female) Weight: 80 kg




Analgesia Morphineþ 0.3 mg∕kg
Table 2 Details of the sheep involved in the ex vivo experiment.
Sheep (Female) Weight: 55 kg
Sedation Tiletamine and Zolazepam (Zoletil®) þAtropine
0.66 mg∕kg
Induction Propofol
Maintenance Fentanyl 0.1 mg∕kgþ Propofol 22.5 mg∕kg
þ 2% isofluorane in 50% N2O∕50% O2
Journal of Biomedical Optics 027002-5 February 2013 • Vol. 18(2)
Ferrari et al.: Continuous haematic pH monitoring in extracorporeal circulation. . .
continuously infused during the experiment in order to keep the
ACT between 300 s and 450 s. The pig was perfused for 9 h in
venous-arterial mode (iliac artery and vein were cannulated
by two bypass cannulas), in normothermic condition (37.5°C
to 38°C). The sheep was perfused for 11 h in venous-arterial
mode (right carotid artery and jugular vein were cannulated by
two bypass cannulas), under controlled hypothermia (33.2°C
and 34.5°C). The pH of blood was sampled with a time interval
of 1 h in each ex vivo experiment, obtaining nine samples in the
ex vivo experiment on the pig and 11 on the sheep. The pictures
of the environment test during the two ex vivo experiments are
shown in Fig. 7.
4 Results
4.1 In Vitro Experimental Results
In Fig. 8, Vratio versus time is shown, for a measurement per-
formed on cow blood, changing the pH of the blood. The dots
are the average values of the Vratio signal recorded at each refer-
ence pH (diamonds), measured by the blood gas analyzer.
During this test, both the flow rate and the temperature of
blood were kept constant, at a value of 2 L∕min and 37°C,
respectively. The pH of the blood was changed using gases,
in particular carbon dioxide and nitrogen. The oxygen was
kept quite constant, thus the saturation was always above 90%.













Fig. 6 Block diagram of the experimental setup for ex vivo evaluation of the measuring system.
Fig. 7 Pictures of the environment test during the experiment performed on the pig (a) and sheep (b).
Fig. 8 V ratio versus time measured in vitro, changing the pH of the
blood. The dots are the average values of the V ratio signal recorded at
each reference pH (diamonds) measured by the blood gas analyzer.
Table 3 Coefficients Ã and B̃ of the regression model and correlation
index, determined considering the mean values of the V ratio (averaged
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The data interpolation was obtained by applying the regres-
sion model on the mean values of Vratio, calculated over a time
interval of 60 s, at each reference pH value. The coefficients Ã, B̃
and the correlation index determined by the regression model
are reported in Table 3.
The linearity and the difference between the pH measured by
our system and the pH determined by the blood gas analyzer are
shown in Fig. 9.







was determined to be 0.0243 units of pH (2.2% of the RoI).
Frequently in cardiac surgery a moderate ipothermia condi-
tion is induced. To investigate the potential influence of this pro-
cedure on the recorded signal, measurements were performed
varying the temperature from 37°C to 32°C. During this test,
the temperature was initially kept at a value of 37°C, then
was brought to 32 °C, and finally changed back to 37°C. In
Fig. 10, Vratio versus time is shown; during the time period
included between the two black vertical dashed lines the temper-
ature was brought to 32°C. The dots are the average values of the
Vratio signal measured at each reference pH (diamonds).
Results of the regression method, calculated considering
only the pH measured at 37°C, applied to the mean values of
the Vratio (averaged over a time interval of 60 s) are shown in
Fig. 11. The diamonds are the reference pH measured at 37°C,
whereas the triangles were measured at 32°C.
Fig. 9 Estimated pH versus reference pH and the interpolation line (a). The interpolation line was obtained by applying the regression model on the
mean values of the V ratio, calculated over an interval of 60 s, at every reference pH value. Difference between the estimated pH and the reference pH,
versus the reference pH (b).
Fig. 10 V ratio versus time measured during an in vitro experiment. The
dots are the average values of the V ratio signal measured at each refer-
ence pH (diamonds). To investigate the potential influence of a mod-
erate ipothermia condition on the recorded signal, the temperature was
initially kept at a value of 37°C, then was brought to 32°C (between the
two black vertical dashed lines), and finally changed back to 37°C.
Fig. 11 Estimated pH versus reference pH and the interpolation line,
obtained by applying the regression model on the mean values of
the V ratio recorded at 37°C. The diamonds are the data acquired at
37°C, whereas the triangles were measured at 32°C.
Table 4 Coefficients Ã and B̃ of the regression model and correlation
index, determined considering the mean values of the V ratio (averaged
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The coefficients Ã, B̃, and the correlation index determined
by the regression model are reported in Table 4.
The mean square errors, calculated according to Eq. (12),
were 0.0150 units of pH for the acquisition at 37°C (1.3%
of the RoI) and 0.0280 for the acquisition at 32°C (2.5% of
the RoI).
4.2 Ex Vivo Experimental Results
In ex vivo experiments, the pH was changed only with little var-
iations, thus avoiding to compromise the physiological func-
tions of the animals. The linearity between the pH measured by
our system and the pH determined by the commercial blood gas
analyzer is shown in Fig. 12. The coefficients ~A, ~B, and the cor-
relation index determined by the regression model are reported
in Table 5.
The mean error was determined to be 0.0038 units of pH
(0.3% of the RoI) for the experiment performed on the sheep
and 0.0208 units of pH (1.9% of the RoI) for the one performed
on the pig.
5 Discussion and Conclusions
Intermittent sampling of blood and the consequent delay
between blood withdraw and pH data availability to medical
staff can represent a critical aspect, especially during unexpected
conditions that might happen during ECC. In this paper, we
present a high correlation (R of 0.9887 and 0.9936 in vitro and
R of 0.9431 and 0.9901 ex vivo) between pH value determined
by our device and pH measured by a commercial blood gas ana-
lyzer during in vitro and ex vivo experiments.
The proposed measuring system that includes a biocompat-
ible film in contact with blood, generated accurate and consis-
tent measurements of blood pH during in vitro and ex vivo
experiments. The continuous and real-time characteristics of
the haematic pH sensor described in this article may improve the
safety of patient management during ECC. The obtained results
demonstrate the possibility of monitoring pH in real-time during
ECC using a disposable sensing element based on the fluores-
ceine O-methacrylate 97%, included in a crosslinked polymer
matrix. Dye leaching is minimized by the covalent link between
the fluorophore and polymer matrix, nevertheless, even in pres-
ence of minimal leaching due to a not complete reaction of flu-
oresceine O-methacrylate this fluorophore is absolutely
biocompatible and not toxic for the patient.
After calibration, we found a mean square error lower than
the 3% of the RoI both for in vitro and ex vivo measurements.
Considering an ipothermic treatment at 32°C, the mean square
error, calculated with the calibration curve obtained considering
only the pH values recorded at 37°C, was lower than 3% of the
measuring range. This means that this sensor is suitable for ipho-
termic treatment without the need of a new calibration curve.
However, a different set of calibration coefficients was
obtained for each sensing element. This variation is mainly asso-
ciated to the reproducibility of the deposition of the polymer
film on the substrate. Therefore a calibration procedure before
each ECC treatment is required. This might be problematic,
since at least two points of calibration are required. This pro-
cedure leads to two main disadvantages: (1) a commercial
blood gas analyzer is always required in order to calibrate
the sensor (limiting its field of application); (2) calibrating the
sensor on a human being may be difficult since, in normal con-
ditions, pH has little variations. This means that the sensor is
likely to be calibrated with two near points, with a high prob-
ability of committing a big error for pH values out of the range
of calibration. These problems could be overcome calibrating
the sensor with two buffer physiological solutions with an
already-known pH. Nevertheless, this approach could be prob-
lematic for perfusionists who are accustomed to use only one
priming physiological solution.
The developed system is not right away suitable for clinical
applications. For this reason, future work will look at the
Fig. 12 Estimated pH measured by our system versus reference pH determined by the commercial blood gas analyzer and the interpolation line,
measured in the ex vivo tests performed on the pig (a) and on the sheep (b).
Table 5 Coefficients Ã and B̃ of the regression model and correlation
index, determined considering the mean values of the V ratio (averaged
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fabrication of the sensing element to improve the repeatability of
the sensors response. In this way, it will be possible to calibrate
some sample sensors of the same production lot before the use
on ECC and then using the same calibration curve for all the
sensors of the lot. Thus it could be possible to use a generic
sensor on ECC just taking a point of calibration, in order to
adjust the calibration offset. Moreover, we are considering to
extend the proposed approach to the measurement of other
blood parameters of interest in ECC, providing the basis for
a multi-analyte blood gas sensor.29,30 This exciting development
could lead to a new valuable clinical sensing tool for continuous
monitoring of blood in ECC.
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